Latest News

Search Results
CMS161v10 - Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS161v11 - Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS161v9 - Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS128v10 - Anti-depressant Medication Management
CMS128v11 - Anti-depressant Medication Management
CMS128v9 - Anti-depressant Medication Management
CMS71v12 - Anticoagulation Therapy for Atrial Fibrillation/Flutter
CMS71v10 - Anticoagulation Therapy for Atrial Fibrillation/Flutter
CMS71v11 - Anticoagulation Therapy for Atrial Fibrillation/Flutter
CMS72v11 - Antithrombotic Therapy By End of Hospital Day 2
CMS72v10 - Antithrombotic Therapy By End of Hospital Day 2
CMS72v9 - Antithrombotic Therapy By End of Hospital Day 2
CMS146v9 - Appropriate Testing for Pharyngitis
CMS146v10 - Appropriate Testing for Pharyngitis
CMS146v11 - Appropriate Testing for Pharyngitis
CMS996v3 - Appropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department (ED)
CMS154v9 - Appropriate Treatment for Upper Respiratory Infection (URI)
CMS154v10 - Appropriate Treatment for Upper Respiratory Infection (URI)
CMS154v11 - Appropriate Treatment for Upper Respiratory Infection (URI)
CMS249v3 - Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS249v4 - Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS249v5 - Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS645v5 - Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS645v6 - Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS645v4 - Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS125v10 - Breast Cancer Screening
CMS125v11 - Breast Cancer Screening
CMS125v9 - Breast Cancer Screening
CMS133v9 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS133v10 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS133v11 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS124v10 - Cervical Cancer Screening
CMS124v11 - Cervical Cancer Screening
CMS124v9 - Cervical Cancer Screening
CMS334v4 - Cesarean Birth
CMS177v9 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS177v10 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS177v11 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS117v10 - Childhood Immunization Status
CMS117v11 - Childhood Immunization Status
CMS117v9 - Childhood Immunization Status
CMS75v9 - Children Who Have Dental Decay or Cavities
CMS75v10 - Children Who Have Dental Decay or Cavities
CMS75v11 - Children Who Have Dental Decay or Cavities
CMS153v9 - Chlamydia Screening for Women
CMS153v10 - Chlamydia Screening for Women
CMS153v11 - Chlamydia Screening in Women
CMS50v9 - Closing the Referral Loop: Receipt of Specialist Report
CMS50v10 - Closing the Referral Loop: Receipt of Specialist Report
CMS50v11 - Closing the Referral Loop: Receipt of Specialist Report
CMS130v10 - Colorectal Cancer Screening
CMS130v11 - Colorectal Cancer Screening
CMS130v9 - Colorectal Cancer Screening
CMS165v9 - Controlling High Blood Pressure
CMS165v10 - Controlling High Blood Pressure
CMS165v11 - Controlling High Blood Pressure
CMS844v3 - Core Clinical Data Elements for the Hybrid Hospital-Wide (All-Condition, All-Procedure) Risk-Standardized Mortality Measure (HWM)
CMS844v2 - Core Clinical Data Elements for the Hybrid Hospital-Wide (All-Condition, All-Procedure) Risk-Standardized Mortality Measure (HWM)
CMS529v3 - Core Clinical Data Elements for the Hybrid Hospital-Wide Readmission (HWR) Measure with Claims and Electronic Health Record Data
CMS529v1 - Core Clinical Data Elements for the Hybrid Hospital-Wide Readmission (HWR) Measure with Claims and Electronic Health Record Data
CMS529v2 - Core Clinical Data Elements for the Hybrid Hospital-Wide Readmission (HWR) Measure with Claims and Electronic Health Record Data
CMS145v9 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)
CMS145v10 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)
CMS145v11 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)
CMS149v9 - Dementia: Cognitive Assessment
CMS149v10 - Dementia: Cognitive Assessment
CMS149v11 - Dementia: Cognitive Assessment
CMS159v9 - Depression Remission at Twelve Months
CMS159v10 - Depression Remission at Twelve Months
CMS159v11 - Depression Remission at Twelve Months
CMS131v9 - Diabetes: Eye Exam
CMS131v10 - Diabetes: Eye Exam
CMS131v11 - Diabetes: Eye Exam
CMS122v10 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS122v11 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS122v9 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS134v9 - Diabetes: Medical Attention for Nephropathy
CMS134v10 - Diabetes: Medical Attention for Nephropathy
CMS142v9 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS142v10 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS142v11 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS104v11 - Discharged on Antithrombotic Therapy
CMS104v9 - Discharged on Antithrombotic Therapy
CMS104v10 - Discharged on Antithrombotic Therapy
CMS105v11 - Discharged on Statin Medication
CMS105v9 - Discharged on Statin Medication
CMS105v10 - Discharged on Statin Medication
CMS68v10 - Documentation of Current Medications in the Medical Record
CMS68v11 - Documentation of Current Medications in the Medical Record
CMS68v12 - Documentation of Current Medications in the Medical Record
CMS9v11 - Exclusive Breast Milk Feeding
CMS9v9 - Exclusive Breast Milk Feeding
CMS9v10 - Exclusive Breast Milk Feeding
CMS139v9 - Falls: Screening for Future Fall Risk
CMS139v10 - Falls: Screening for Future Fall Risk
CMS139v11 - Falls: Screening for Future Fall Risk
CMS136v10 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS136v11 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS136v12 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS56v9 - Functional Status Assessment for Total Hip Replacement
CMS56v10 - Functional Status Assessment for Total Hip Replacement
CMS56v11 - Functional Status Assessment for Total Hip Replacement
CMS66v9 - Functional Status Assessment for Total Knee Replacement
CMS66v10 - Functional Status Assessment for Total Knee Replacement
CMS90v10 - Functional Status Assessments for Congestive Heart Failure
CMS90v11 - Functional Status Assessments for Heart Failure
CMS90v12 - Functional Status Assessments for Heart Failure
CMS986v1 - Global Malnutrition Composite Score
CMS135v9 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v10 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v11 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v9 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v10 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v11 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS349v3 - HIV Screening
CMS349v4 - HIV Screening
CMS349v5 - HIV Screening
CMS819v1 - Hospital Harm - Opioid-Related Adverse Events
CMS871v2 - Hospital Harm - Severe Hyperglycemia
CMS816v2 - Hospital Harm - Severe Hypoglycemia
CMS137v9 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS137v10 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS137v11 - Initiation and Engagement of Substance Use Disorder Treatment
CMS190v11 - Intensive Care Unit Venous Thromboembolism Prophylaxis
CMS190v9 - Intensive Care Unit Venous Thromboembolism Prophylaxis
CMS190v10 - Intensive Care Unit Venous Thromboembolism Prophylaxis
CMS646v2 - Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
CMS646v3 - Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
CMS951v1 - Kidney Health Evaluation
CMS111v11 - Median Admit Decision Time to ED Departure Time for Admitted Patients
CMS111v9 - Median Admit Decision Time to ED Departure Time for Admitted Patients
CMS111v10 - Median Admit Decision Time to ED Departure Time for Admitted Patients
CMS157v9 - Oncology: Medical and Radiation - Pain Intensity Quantified
CMS157v10 - Oncology: Medical and Radiation - Pain Intensity Quantified
CMS157v11 - Oncology: Medical and Radiation - Pain Intensity Quantified
CMS127v10 - Pneumococcal Vaccination Status for Older Adults
CMS127v11 - Pneumococcal Vaccination Status for Older Adults
CMS127v9 - Pneumococcal Vaccination Status for Older Adults
CMS69v9 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS69v10 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS69v11 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS147v10 - Preventive Care and Screening: Influenza Immunization
CMS147v11 - Preventive Care and Screening: Influenza Immunization
CMS147v12 - Preventive Care and Screening: Influenza Immunization
CMS2v10 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS2v11 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS2v12 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS22v9 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS22v10 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS22v11 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS138v9 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS138v10 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS138v11 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS74v12 - Primary Caries Prevention Intervention as Offered by Dentists
CMS74v10 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS74v11 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS143v9 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS143v10 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS143v11 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS129v11 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS129v12 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS129v10 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS506v5 - Safe Use of Opioids - Concurrent Prescribing
CMS506v3 - Safe Use of Opioids - Concurrent Prescribing
CMS506v4 - Safe Use of Opioids - Concurrent Prescribing
CMS1028v1 - Severe Obstetric Complications
CMS347v4 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS347v5 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS347v6 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS771v2 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS771v3 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS771v4 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS156v9 - Use of High-Risk Medications in Older Adults
CMS156v10 - Use of High-Risk Medications in Older Adults
CMS156v11 - Use of High-Risk Medications in Older Adults
CMS108v11 - Venous Thromboembolism Prophylaxis
CMS108v9 - Venous Thromboembolism Prophylaxis
CMS108v10 - Venous Thromboembolism Prophylaxis
CMS155v9 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS155v10 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
CMS155v11 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents

Search Results

CMS145v9 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)

CMS145v10 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)

CMS145v11 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)

CMS149v9 - Dementia: Cognitive Assessment

CMS149v10 - Dementia: Cognitive Assessment

CMS149v11 - Dementia: Cognitive Assessment

CMS159v9 - Depression Remission at Twelve Months

CMS159v10 - Depression Remission at Twelve Months

CMS159v11 - Depression Remission at Twelve Months

CMS131v9 - Diabetes: Eye Exam

CMS131v10 - Diabetes: Eye Exam

CMS131v11 - Diabetes: Eye Exam

CMS122v10 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)

CMS122v11 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)

CMS122v9 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)

CMS134v9 - Diabetes: Medical Attention for Nephropathy

CMS134v10 - Diabetes: Medical Attention for Nephropathy

CMS142v9 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

CMS142v10 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

CMS142v11 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

CMS104v11 - Discharged on Antithrombotic Therapy

CMS104v9 - Discharged on Antithrombotic Therapy

CMS104v10 - Discharged on Antithrombotic Therapy

CMS105v11 - Discharged on Statin Medication

CMS105v9 - Discharged on Statin Medication

CMS105v10 - Discharged on Statin Medication

CMS68v10 - Documentation of Current Medications in the Medical Record

CMS68v11 - Documentation of Current Medications in the Medical Record

CMS68v12 - Documentation of Current Medications in the Medical Record

CMS9v11 - Exclusive Breast Milk Feeding

CMS9v9 - Exclusive Breast Milk Feeding

CMS9v10 - Exclusive Breast Milk Feeding

CMS139v9 - Falls: Screening for Future Fall Risk

CMS139v10 - Falls: Screening for Future Fall Risk

CMS139v11 - Falls: Screening for Future Fall Risk

CMS136v10 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)

CMS136v11 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)

CMS136v12 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)

CMS56v9 - Functional Status Assessment for Total Hip Replacement

CMS56v10 - Functional Status Assessment for Total Hip Replacement

CMS56v11 - Functional Status Assessment for Total Hip Replacement

CMS66v9 - Functional Status Assessment for Total Knee Replacement

CMS66v10 - Functional Status Assessment for Total Knee Replacement

CMS90v10 - Functional Status Assessments for Congestive Heart Failure

CMS90v11 - Functional Status Assessments for Heart Failure

CMS90v12 - Functional Status Assessments for Heart Failure

CMS986v1 - Global Malnutrition Composite Score

CMS135v9 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS135v10 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS135v11 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS144v9 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS144v10 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS144v11 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS349v3 - HIV Screening

CMS349v4 - HIV Screening

CMS349v5 - HIV Screening

CMS819v1 - Hospital Harm - Opioid-Related Adverse Events

CMS871v2 - Hospital Harm - Severe Hyperglycemia

CMS816v2 - Hospital Harm - Severe Hypoglycemia

CMS137v9 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment

CMS137v10 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment

CMS137v11 - Initiation and Engagement of Substance Use Disorder Treatment

CMS190v11 - Intensive Care Unit Venous Thromboembolism Prophylaxis

CMS190v9 - Intensive Care Unit Venous Thromboembolism Prophylaxis

CMS190v10 - Intensive Care Unit Venous Thromboembolism Prophylaxis

CMS646v2 - Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer

CMS646v3 - Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer

CMS951v1 - Kidney Health Evaluation

CMS111v11 - Median Admit Decision Time to ED Departure Time for Admitted Patients

CMS111v9 - Median Admit Decision Time to ED Departure Time for Admitted Patients

CMS111v10 - Median Admit Decision Time to ED Departure Time for Admitted Patients

CMS157v9 - Oncology: Medical and Radiation - Pain Intensity Quantified

CMS157v10 - Oncology: Medical and Radiation - Pain Intensity Quantified

CMS157v11 - Oncology: Medical and Radiation - Pain Intensity Quantified

CMS127v10 - Pneumococcal Vaccination Status for Older Adults

CMS127v11 - Pneumococcal Vaccination Status for Older Adults

CMS127v9 - Pneumococcal Vaccination Status for Older Adults

CMS69v9 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

CMS69v10 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

CMS69v11 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

CMS147v10 - Preventive Care and Screening: Influenza Immunization

CMS147v11 - Preventive Care and Screening: Influenza Immunization

CMS147v12 - Preventive Care and Screening: Influenza Immunization

CMS2v10 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan

CMS2v11 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan

CMS2v12 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan

CMS22v9 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

CMS22v10 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

CMS22v11 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

CMS138v9 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS138v10 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS138v11 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS74v12 - Primary Caries Prevention Intervention as Offered by Dentists

CMS74v10 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists

CMS74v11 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists

CMS143v9 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation

CMS143v10 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation

CMS143v11 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation

CMS129v11 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CMS129v12 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CMS129v10 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CMS506v5 - Safe Use of Opioids - Concurrent Prescribing

CMS506v3 - Safe Use of Opioids - Concurrent Prescribing

CMS506v4 - Safe Use of Opioids - Concurrent Prescribing

CMS1028v1 - Severe Obstetric Complications

CMS347v4 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

CMS347v5 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

CMS347v6 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

CMS771v2 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

CMS771v3 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

CMS771v4 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

CMS156v9 - Use of High-Risk Medications in Older Adults

CMS156v10 - Use of High-Risk Medications in Older Adults

CMS156v11 - Use of High-Risk Medications in Older Adults

CMS108v11 - Venous Thromboembolism Prophylaxis

CMS108v9 - Venous Thromboembolism Prophylaxis

CMS108v10 - Venous Thromboembolism Prophylaxis

CMS155v9 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents

CMS155v10 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents

CMS155v11 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents

2023 HL7 FHIR Connectathon 33: In-person (New Orleans)

We would like to inform you of the upcoming HL7® FHIR® Connectathon taking place May 6-7, 2023, in-person, in New Orleans, LA. Please note there will be no hybrid option to include virtual attendance, the event will be in-person only. There is a fee to attend the HL7 FHIR Connectathon and early-… Posted on Mar 28, 2023

Now Accepting Public Comments on the Draft 2024 CMS QRDA I Implementation Guide (IG) for Hospital Quality Reporting (HQR)

The Centers for Medicare & Medicaid Services (CMS) has posted the draft 2024 CMS Quality Reporting Document Architecture (QRDA) Category I Implementation Guide (IG) for Hospital Quality Reporting (HQR) for public comment starting on March 28, 2023, and ending at 5 p.m. eastern time (ET) on… Posted on Mar 28, 2023

Now Available: Updated 2023 CMS QRDA I Implementation Guide (IG) and Schematron for Hospital Quality Reporting

The Centers for Medicare & Medicaid Services (CMS) has published an update to the 2023 CMS Quality Reporting Document Architecture (QRDA) Category I Implementation Guide (IG) and Schematron for Hospital Quality Reporting. This is an update to the IG version 1.1 published in January 2023. The… Posted on Mar 23, 2023

Seeking Public Comment on Diabetic Foot Assessment and Follow-Up Measure

On behalf of the Centers for Medicare & Medicaid Services (CMS), Mathematica and the National Committee for Quality Assurance are developing and testing a new clinical quality measure: Diabetic Foot Assessment and Follow-Up. This measure assesses the percentage of patients ages 18 years and… Posted on Mar 08, 2023

Materials and Recording for Performance Period 2023 Eligible Clinician Electronic Clinical Quality Measure (eCQM) Education and Outreach Webinar

The Centers for Medicare & Medicaid Services (CMS) developed and published webinar content from the Performance Period 2023 Eligible Clinician Electronic Clinical Quality Measure (eCQM) Education and Outreach Webinar. Webinar slides in PDF format and links to the webinar video recording are… Posted on Feb 28, 2023

Now Available: 2023 CMS QRDA I Implementation Guide (IG), Schematron, and Sample Files for Hospital Quality Reporting (HQR)

The Centers for Medicare & Medicaid Services (CMS) has published the 2023 CMS Quality Reporting Document Architecture (QRDA) Category I Implementation Guide (IG), Schematron, and Sample Files for Hospital Quality Reporting (HQR). The 2023 CMS QRDA I IG outlines requirements for eligible… Posted on Jul 20, 2022

View Archived News

Electronic Clinical Quality Improvement (eCQI) Resource Center

Featured News & Events

Latest News

Upcoming Events

Cypress Tech Talks

eCQI Resource Center Website User Group

HIMSS: Minimizing Burden in Federal Quality Measurement and Public Health Reporting

QDI User Group Webinar

HIMSS: MedMorph: FHIRing Up Automated Data Exchange